Clementia Pharmaceuticals Inc (CMTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 94,973 | 12,057 | 12,937 | 26,639 | 36,230 |
| Marketable Securities | 75,000 | 70,000 | 55,000 | 30,000 | 30,000 |
| Receivables | 1,761 | 1,394 | 2,679 | 2,168 | 1,648 |
| TOTAL | $174,140 | $88,061 | $76,524 | $61,173 | $70,901 |
| Non-Current Assets | |||||
| PPE Net | 8 | 19 | 24 | 28 | 33 |
| Investments And Advances | 0 | 25,000 | 50,000 | 75,000 | 75,000 |
| Intangibles | 1,658 | 1,571 | 1,619 | 1,668 | 1,715 |
| Other Non-Current Assets | 1,039 | 733 | 0 | 0 | 776 |
| TOTAL | $2,705 | $27,323 | $51,643 | $76,696 | $77,524 |
| Total Assets | $176,844 | $115,383 | $128,167 | $137,869 | $148,425 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,412 | 8,792 | 8,455 | 8,662 | 6,719 |
| TOTAL | $12,412 | $8,792 | $8,455 | $8,662 | $6,719 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $12,412 | $8,792 | $8,455 | $8,662 | $6,719 |
| Shareholders' Equity | |||||
| Common Shares | 306,557 | 230,660 | 230,660 | 230,660 | 230,660 |
| Retained earnings | -149,739 | -130,388 | -115,611 | -104,844 | -91,612 |
| TOTAL | $164,432 | $106,591 | $119,712 | $129,207 | $141,707 |
| Total Liabilities And Equity | $176,844 | $115,383 | $128,167 | $137,869 | $148,425 |